Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 2/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7297468 | 0.92 | DRD3 (0.41) | PARP1DRD3SIGMAR1KDM4EHTR7 | |
| SCHEMBL7301503 | 0.90 | HTR7 (0.43) | PARP1DRD3SIGMAR1KDM4EHTR7 | |
| SCHEMBL7359856 | 0.90 | KDM4E (0.44) | PARP1DRD3SIGMAR1KDM4EHTR7 | |
| SCHEMBL7310797 | 0.87 | DRD3 (0.38) | DRD3SIGMAR1KDM4EHTR7ALDH1A1 | |
| SCHEMBL7308008 | 0.85 | SIGMAR1 (0.42) | PARP1DRD3SIGMAR1KDM4EHTR7 | |
| SCHEMBL7307713 | 0.85 | HTR7 (0.44) | PARP1DRD3SIGMAR1KDM4EHTR7 | |
| SCHEMBL7310638 | 0.84 | KDM4E (0.43) | PARP1SIGMAR1KDM4EHTR7ALDH1A1 | |
| SCHEMBL7307166 | 0.83 | KDM4E (0.43) | PARP1SIGMAR1KDM4EHTR7ALDH1A1 | |
| SCHEMBL7360979 | 0.82 | DRD3 (0.44) | PARP1DRD3SIGMAR1KDM4EHTR7 | |
| SCHEMBL7300303 | 0.81 | HTR1A (0.46) | PARP1DRD3SIGMAR1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5304560-A | Treating CNS disorders; dopamine receptor antagonist | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-04-19 | — | — | US | disclosed |
| EP-0481342-A1 | Quinazoline derivatives and their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-22 | — | — | EP | disclosed |